Clinical Trials Directory

Trials / Conditions / Stage IVA Colon Cancer AJCC v8

Stage IVA Colon Cancer AJCC v8

10 registered clinical trials studyying Stage IVA Colon Cancer AJCC v8 — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingMicrobiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
NCT05296681
Howard S. Hochster, MDPhase 2
Active Not RecruitingEnhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events
NCT05038254
M.D. Anderson Cancer CenterN/A
Completed18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
NCT04752267
University of Southern CaliforniaEARLY_Phase 1
Active Not RecruitingLY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastat
NCT04616183
M.D. Anderson Cancer CenterPhase 1 / Phase 2
Active Not RecruitingSX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the S
NCT04599140
M.D. Anderson Cancer CenterPhase 1 / Phase 2
CompletedRegorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metast
NCT04362839
City of Hope Medical CenterPhase 1
Active Not RecruitingPanitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type C
NCT03992456
Academic and Community Cancer Research UnitedPhase 2
TerminatedGenetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Tr
NCT03765736
Academic and Community Cancer Research United—
TerminatedSavolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer
NCT03592641
National Cancer Institute (NCI)Phase 2
CompletedM7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instabil
NCT03436563
M.D. Anderson Cancer CenterPhase 1 / Phase 2